Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis
- 1 December 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (23), 6067-6072
- https://doi.org/10.1016/j.bmcl.2006.08.102
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationshipsBioorganic & Medicinal Chemistry Letters, 2005
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)Journal of Medicinal Chemistry, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Cytokine Pathways and Joint Inflammation in Rheumatoid ArthritisThe New England Journal of Medicine, 2001
- TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent PathwayCell, 2000
- Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-junPromoter and to Cellular TransformationMolecular and Cellular Biology, 2000
- The Role of TNFα and IL-1 in Rheumatoid ArthritisCurrent directions in autoimmunity, 2000
- The TAO of MEKKFrontiers in Bioscience-Landmark, 1998
- Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.Molecular and Cellular Biology, 1991